Bellerophon Therapeutics, Inc.BLPH

Market cap

$146.79K

P/E ratio

	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12
Cash and cash equivalents	6	14	29	17	10	48	25	7
Total cash & short-term investments	6	14	29	17	10	48	25	7
Total current assets	29	27	36	17	10	48	25	8
Property, plant and equipment, net	2	1	1	1	0	0	0	0
Total non-current assets	9	3	1	1	3	2	1	0
Total assets	38	30	37	18	13	50	27	8
Total current liabilities	8	6	7	8	8	10	5	5
Total non-current liabilities	-	5	32	7	2	2	0	-
Total liabilities	8	12	39	15	10	12	5	5
Common stock and paid-in capital	131	142	177	180	193	253	254	255
Retained earnings	-101	-124	-179	-176	-190	-214	-232	-252
Stockholders' equity	30	18	-3	4	4	38	22	3